[EN] 3,4-DIHYDROQUINOLIN-2-ONE, 5,6-FUSED OXAZIN-3-ONE, AND 5,6-FUSED THIAZIN-3-ONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS<br/>[FR] INHIBITEURS DE METALLOPROTEASES MATRICES A BASE DE DERIVES DE 3,4-DIHYDROQUINOLINE-2-ONE, D'OXAZINE-3-ONE FUSIONNEE EN 5,6, ET DE THIAZINE-3-ONE FUSIONNEE EN 5,6
申请人:WARNER LAMBERT CO
公开号:WO2004014389A1
公开(公告)日:2004-02-19
This invention provides compounds'defined by Formula I or a pharmaceutically acceptable salt thereof,wherein Rt, Q, Y1, Y5, Y6, Y8, R2, R2a, and R4 are as defined in the specification. The invention also provides pharmaceutical compositions comprising a compound of Formula I and the use of the compounds of Formula .1 as matrix metalloproteinase inhibitors.